Supplementary Files
Keywords
Early Presentation
Late Presentation
How to Cite
Abstract
Objective: To compare the factors that lead to early versus late presentation in patients with neck masses
Study Design: Group Comparative Study.
Study Setting & Duration: Department of Otorhinolaryngology and Head &Neck Surgery at Rawalpindi Teaching Hospital from 01-9-2022 to 01-03-2023.
Methods: Approval of the study was obtained from the hospital's ethical committee. A total of 64 patients (32 in each group) were placed in two Groups A & B. Group A included patients who presented early and Group B included patients who presented late. Both male and female patients were selected. In this study patients suffering from neck masses who have reported for work-up to the Department of ENT, Rawalpindi Teaching Hospital, and fulfil the complete inclusion and exclusion criteria were included. Patients were selected via consecutive nonprobability sampling. The data were analyzed for frequencies by SPSS 24.
Results: A total of 64 patients were included in this study. In the majority of patients, the size of mass more than 1.5 cm (51.56%) revealed malignancy, while only a small percentage of patients (48.44%) had less than 1.5 cm neck mass.
Conclusion: The majority of patients who were drug and alcohol addicts were presented late with advanced disease. Both groups were considered to be significant (p=0.00) based on the probability ratio. This study helped to identify the role of various suspected risk factors for late presentation in head and neck cancers in an attempt to reinforce or negate their importance which will help to guide the formation of screening protocols thereby improving morbidity, and mortality and reducing financial costs.
Keywords: Neck masses, Early Presentation, Late Presentation.
References
Nandakumar A. National Cancer Registry Programme. Consolidated Report of the Population Based Cancer Registries. Incidence and Distribution of Cancer: 1990–96. Indian Council of Medical Research, New Delhi. Cancer. 2019;125:3184-97.
Goy J, Hall SF, Feldman-Stewart D, Groome PA. Diagnostic delay and disease stage in head and neck cancer:a systematic review. Laryngoscope.2019; 119: 889-98.
Polesel J, Lupato V, Collarile P, et al. Direct health-care cost of head and neck cancers: a population-based study in north-eastern Italy. Med Oncol 2019; 36:31 DOI:10.1007/s12032-019-1256-2 10.1007/s12032-019-1256-2
Morelatto RA, Herrera MC, Fernandez EN, Corball AG, Lopezde Blanc SA . Diagnostic delay of oral squamous cell carcinoma in two diagnosis centers in Cordoba Argentina.J Oral Pathol Med. 2019; 36: 405-8.
Joshi P, Nair S, Chaturvedi P, Nair D, Agarwal JP. Delay in seekingspecialized care for oral cancers: Experience from a tertiarycancer center. Indian J Cancer. 2020;51: 95-7.
Li Y, Hu C. Early death incidence and prediction among patients with hypopharynx squamous cell carcinomas. Ear, Nose & Throat Journal. 2023:01455613231192282.
D’Souza G, Kreimer AR, Viscidi R, et al. Case-control study of human papillomavirus and oropharyngeal cancer. New England Journal of Medicine. 2019; 356:1944–1956.
Albergotti WG, Abberbock S, Mathews F, Ferris RL, Johnson JT, Duvvuri U, Kim S. Oligometastatic status as predictor of survival in metastatic human papillomavirus-positive oropharyngeal carcinoma. Head Neck 2018; 40: 1685-90. DOI:10.1002/hed.25171 10.1002/hed.25171
Bates JE, De Leo AN, Morris CG, et al. Oligometastatic squamous cell carcinoma of the head and neck treated with stereotactic body ablative radiotherapy: single-institution outcomes. Head Neck 2019; 41: 2309-14. DOI:10.1002/hed.25695 10.1002/hed.25695
Lilly-Tariah OB, Somefun OA, Adeyemo WL. Current evidence on the burden of head and neck cancers in Nigeria. Head Neck Oncol 2019; 1: 14.
Boulahssass R, Gonfrier S, Sanchez M, et al. Predicting early death in older adults with cancer. Eur J Cancer 2018; 100: 65-74. https://doi.org/10.1016/j.ejca.2018.04.013.DOI: 10.1016/j.ejca.2018.04.013
Grandazzi G, Roussel LM, Cuny F, et al. Impact of head and neck cancer on partner’s sociability. Eur Ann Otorhinolaryngol Head Neck Dis 2019; 136: 165-8.DOI:10.1016/j.anorl.2019.02.017.
Moschopoulou E, Hutchinson I, Bhui K,Korszun A. Post-traumatic stress in head and neck cancer survivors and their partners. Support Care Cancer 2018; 26: 3003-11. DOI:10.1007/s00520-018-4146-9.
Duprez F, Berwouts D, De Neve W, Bonte K, Boterberg T. Distant metastases in head and neck cancer. Head Neck 2017; 39: 1733-43. DOI:10.1002/hed.24687.
Liu JC, Bhayani M, Kuchta K, Galloway T, Fundakowski C. Patterns of distant metastasis in head and neck cancer at presentation: implications for initial evaluation. Oral Oncology. 2019; 88: 131-6. DOI:10.1016/j.oraloncology.2018.11.023.
Osifo OD, Ugiagbe EE: Neck masses in children: Etiopathology in a tertiary center. Niger J ClinPract. 2021;14: 232-236.
Ayugi JW, Ogeng’o JA, Macharia IM: Pattern of congenital neck masses in a Kenya paediatric population. International Journal Pediatr Otorhinolaryngol. 2020; 7 (4): 64-66.
Pisani P, Airoldi M, Allais A, Valletti PA, Battista M, Benazzo M, Briatore R, Cacciola S, Cocuzza S, Colombo A, Conti B. La malattia metastatica in oncologia testa-collo. Acta Otorhinolaryngologica Italica. 2020;40(2):S1-86.
Melchardt T, Magnes T, Hufnagl C, et al. Clonal evolution and heterogeneity in metastatic head and neck cancer - an analysis of the Austrian Study Group of Medical Tumour Therapy study group. Europian Journal of Cancer. 2018; 93: 69-78. DOI:10.1016/j.ejca.2018.01.064
Goldenberg D, Begum S, Westra WH, Khan Z, Sciubba J, Pai SI, Califano JA, Tufano RP, Koch WM. Cystic lymph node metastasis in patients with head and neck cancer: an HPV‐associated phenomenon. Head & Neck: Journal for the Sciences and Specialties of the Head and Neck. 2008 Jul;30(7):898-903.
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Copyright (c) 2023 Ansa Umara Akram, Sadia Chaudhry, Nighat Qamar, Amna Kausar, Amna Javaid, Adia Bushra Piracha